Changes of liver fat content and transaminases in obese children after 12-mo nutritional intervention

Elvira Verduci1, Carlo Pozzato, Giuseppe Banderali

  • 1Elvira Verduci, Giuseppe Banderali, Giovanni Radaelli, Chiara Arrizza, Enrica Riva, Marcello Giovannini, Department of Pediatrics, San Paolo Hospital, University of Milan, 20142 Milan, Italy.

World Journal of Hepatology
|September 28, 2013
PubMed

Insights

Nutritional intervention in obese children reduced liver fat content and improved liver enzymes. Changes in liver fat fraction (FF) correlated with changes in aspartate aminotransferase (AST) and alanine aminotransferase (ALT), suggesting a new monitoring approach for fatty liver disease.

Area of Science:

  • Pediatric Endocrinology
  • Hepatology
  • Radiology
  • Nutritional Science

Background:

  • Childhood obesity is a growing concern, often associated with nonalcoholic fatty liver disease (NAFLD).
  • Accurate monitoring of liver fat content and its biochemical markers is crucial for assessing intervention effectiveness in obese children.

Purpose of the Study:

  • To investigate the relationship between changes in liver fat content and biochemical parameters in obese children following a 1-year nutritional intervention.
  • To explore the potential of magnetic resonance imaging (MRI) in monitoring NAFLD progression and treatment response in pediatric populations.

Main Methods:

  • Forty-six obese children (aged 6-14 years) underwent baseline and 1-year follow-up assessments.
  • Assessments included body mass index (BMI) Z-scores, serum alanine aminotransferase (ALT) and aspartate aminotransferase (AST) levels, liver ultrasonography (US), and chemical-shift MRI to determine liver fat fraction (FF).
  • A nutritional-behavioral intervention focused on a balanced diet and active lifestyle was implemented.

Main Results:

  • The intervention led to significant reductions in energy, fat, carbohydrate, and protein intake.
  • Prevalence of elevated liver fat fraction (FF ≥ 9%) decreased from 34.8% to 8.7% (P < 0.01), with a mean reduction of 7.8%.
  • Changes in liver fat fraction (FF) were significantly associated with changes in AST (P = 0.027) and ALT (P = 0.024). FF change was independently associated with AST change (adjusted regression coefficient 0.348, P = 0.048).

Conclusions:

  • Longitudinal changes in liver fat content, measured by MRI, are associated with changes in serum transaminases in obese children.
  • These findings suggest that MRI-based liver fat assessment, combined with biochemical markers, may offer a novel approach for monitoring NAFLD in pediatric obesity.
Abstract

Related Concept Videos

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion01:20

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion

Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in adipocytes...
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...